Biosynex SA operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other
pharmaceutical manufacturers in Europe:
sales of 19.21 million Euro [US$20.44 million]
of which 94%
was Product Sales),
Millet Innovation Sa
(21.81 million Euro [US$23.20 million]
of which 93%
was Pharmacies & Pharmaceutical Wholesale De), and
Mithra Pharmaceuticals SA
based in Belgium
(20.44 million Euro [US$21.74 million]
Sales increased substantially in 2015:
During the year ended December of 2015, sales at
Biosynex SA were 20.13 million Euro (US$21.42 million).
increase of 394.2%
versus 2014, when the company's sales were 4.07 million Euro.
This was the fifth consecutive year of sales increases at Biosynex SA
(and since 2010, sales have increased a total of 1,899%).
Sales of Services saw an increase
that was more than double the company's growth rate: sales were up
1,415.1% in 2015, from
76,876.00 Euro to 1.16 million Euro.